📊 NROM Key Takeaways
Is NROM a Good Investment? Thesis Analysis
Noble Romans demonstrates solid profitability metrics with strong operating margins (18.6%) and ROE (33.7%), but faces significant liquidity constraints that undermine financial stability. The company's weak current ratio (0.40x), elevated leverage (1.29x debt/equity), and deteriorating EPS (-100% YoY) indicate operational challenges that warrant cautious monitoring despite positive free cash flow generation.
Why Buy NROM? Key Strengths
- Strong operating margin of 18.6% demonstrates efficient cost management relative to revenue
- Healthy free cash flow of $801.2K and positive operating cash flow indicate underlying business generates cash
- High ROE of 33.7% suggests efficient use of shareholder capital in generating profits
NROM Investment Risks to Consider
- Severe liquidity crisis with current ratio of 0.40x and quick ratio of 0.27x; company cannot cover short-term obligations with current assets
- High leverage with debt-to-equity of 1.29x and weak interest coverage of 1.9x creates vulnerability to interest rate changes
- Dramatic EPS decline of -100% YoY signals deteriorating per-share profitability despite revenue growth, suggesting dilution or reduced earnings allocation
Key Metrics to Watch
- Current ratio and working capital trends; company needs to improve liquidity position to 1.0x+ for financial stability
- Debt reduction progress and interest coverage ratio; need to see improvement above 2.5x to reduce financial risk
- EPS recovery and per-share profitability; critical to validate whether earnings gains translate to shareholder value
NROM Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
NROM Profitability Ratios
NROM vs Consumer Sector
How NOBLE ROMANS INC compares to Consumer sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is NROM Overvalued or Undervalued?
Based on fundamental analysis, NOBLE ROMANS INC has mixed fundamental signals relative to the Consumer sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
NROM Balance Sheet & Liquidity
NROM 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: NOBLE ROMANS INC's revenue has grown significantly by 22% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.07 reflects profitable operations.
NROM Growth Metrics (YoY)
NROM Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $3.9M | $163.7K | $0.01 |
| Q2 2025 | $3.9M | -$29.6K | $0.00 |
| Q1 2025 | $3.7M | -$86.5K | $0.00 |
| Q3 2024 | $3.7M | $154.5K | $0.01 |
| Q2 2024 | $3.8M | -$29.6K | $0.00 |
| Q1 2024 | $3.3M | -$86.5K | $0.00 |
| Q3 2023 | $3.7M | $3.9K | $0.00 |
| Q2 2023 | $3.7M | -$50.3K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
NROM Capital Allocation
NROM SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for NOBLE ROMANS INC (CIK: 0000709005)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NROM
What is the AI rating for NROM?
NOBLE ROMANS INC (NROM) has an AI rating of HOLD with 45% confidence, based on fundamental analysis of SEC EDGAR filings.
What are NROM's key strengths?
Claude: Strong operating margin of 18.6% demonstrates efficient cost management relative to revenue. Healthy free cash flow of $801.2K and positive operating cash flow indicate underlying business generates cash.
What are the risks of investing in NROM?
Claude: Severe liquidity crisis with current ratio of 0.40x and quick ratio of 0.27x; company cannot cover short-term obligations with current assets. High leverage with debt-to-equity of 1.29x and weak interest coverage of 1.9x creates vulnerability to interest rate changes.
What is NROM's revenue and growth?
NOBLE ROMANS INC reported revenue of $12.0M.
Does NROM pay dividends?
NOBLE ROMANS INC does not currently pay dividends.
Where can I find NROM SEC filings?
Official SEC filings for NOBLE ROMANS INC (CIK: 0000709005) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NROM's EPS?
NOBLE ROMANS INC has a diluted EPS of $0.04.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is NROM a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, NOBLE ROMANS INC has a HOLD rating with 45% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is NROM stock overvalued or undervalued?
Valuation metrics for NROM: ROE of 33.7% (sector avg: 18%), net margin of 9.5% (sector avg: 8%). Higher ROE suggests strong returns relative to peers.
Should I buy NROM stock in 2026?
Our dual AI analysis gives NOBLE ROMANS INC a combined HOLD rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is NROM's free cash flow?
NOBLE ROMANS INC's operating cash flow is $915.6K, with capital expenditures of $114.5K. FCF margin is 6.7%.
How does NROM compare to other Consumer stocks?
Vs Consumer sector averages: Net margin 9.5% (avg: 8%), ROE 33.7% (avg: 18%), current ratio 0.40 (avg: 1.5).